{
  "docId": "019de074-a700-7657-a81b-294badb4027d",
  "docSlug": "67e79e002ddeb617e9341b6e20b69755",
  "documentTitle": "Absci | Investor Presentation Deck | 27 slides",
  "authorId": "absci",
  "authorName": "Absci",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 27,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a two-column bulleted list to contrast traditional methods with their AI-driven approach and the resulting benefits.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-a700-7657-a81b-294badb4027d/7",
  "deckHref": "/decks/019de074-a700-7657-a81b-294badb4027d",
  "deckJsonHref": "/decks/019de074-a700-7657-a81b-294badb4027d.json",
  "deckAnchorHref": "/decks/019de074-a700-7657-a81b-294badb4027d#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.45,
        "x": 0.51,
        "y": 0.41
      },
      "kind": "list",
      "text": "This potentially reduces the time it takes to get new drug leads into the clinic, while unlocking treatments for traditionally \"undruggable\" diseases and improved therapeutic possibilities for many others. Biologics, and the ability to pursue \"undruggable\" targets, offer the greatest promise for indications never previously able to see benefits from traditional small molecule drugs.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e1e534d-97aa-4e18-99f1-8f0e73157164",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.45,
        "x": 0.04,
        "y": 0.41
      },
      "kind": "list",
      "text": "Most drug discovery approaches today look to existing antibody libraries for incremental improvements. We recently showed how we design de novo antibodies \"from scratch\" on a computer. Our zero-shot AI approach designs antibodies without prior learning on the specific target, generating candidates unlike those found in existing databases. Our wet lab can experimentally validate the candidates that work right out of the computer - without the slow and costly step of lead optimization.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f6662d7d-78b4-47b9-b279-98b7590deff6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.45,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "A BETTER, FASTER PATH TO NEW MEDICINES",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7a6bd637-a5ba-4489-b57c-96e78f5fec11",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.55,
        "x": 0.04,
        "y": 0.09
      },
      "kind": "title",
      "text": "Designing antibodies \"from scratch\"",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0101c9f9-759c-4da0-a07e-98cf9f345d16",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 11,
      "from": 7,
      "beatId": "0bf93ca6-44e9-4fac-a111-e388cf78bd8b",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Solution",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The presentation showcases Absci's solution and its benefits",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 4,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "b9223192-4724-4971-825b-5c4b9c320e0d",
      "evidence": "The presentation showcases Absci's mission and its benefits",
      "position": 1,
      "objective": "Why is Absci's mission important?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    },
    {
      "to": 7,
      "from": 6,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "1e45bdee-573a-4e3e-b0ce-fc3dfb51c5ec",
      "evidence": "The presentation highlights the emerging innovative approach",
      "position": 2,
      "objective": "Why is now the right time for Absci's solution?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.7,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}